Vereos is a fully digital, clinically proven PET/CT solution supported by rigorous clinical evidence, including more than four years of investigational studies and over 100 published clinical studies. Vereos is a well-established, comprehensive solution to help clinicians improve patient care and manage costs. Featuring Philips’ proprietary Digital Photon Counting (DPC) technology, Vereos offers improved detectability and characterization of small lesions.1 The system provides uncompromised detectability and quantification at half the PET dose.2 Vereos also provides lesion detectability in one tenth of the time.3
[1] Nguyen NC, Image Quality and Diagnostic Performance of a Digital PET Prototype in Patients with Oncologic Diseases: Initial Experience and Comparison with Analog PET, J Nucl Med 2015; 56:1378–1385
[2] Knopp,M, Binzel,K, Bardos,P, Knopp,M, Wright,C, Zhang,J, Nagar,V, Hall,N, Maniawski,P, Next Generation Digital PET/CT: A Phase I Intra-Individual Comparison with Current Photomultiplier TOF PET/CT. Radiological Society of North America 2015 Scientific Assembly and Annual Meeting, November 29 – December 4, 2015, Chicago IL.
[3] Zhang J., Evaluation of speed of PET acquisition: How fast can we go? – A validation of list mode PET simulation approach with true acquisitions, SNMMI 2017
